COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 1661: Articles 16601-16610  | Next

A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil
Resende, P. C., Graf, T., Paixao, A. C. D., Appolinario, L., Lopes, R. S., Mendonca, A. C. F., da Rocha, A. S. B., Motta, F. C., Neto, L. G. L., Khouri, R., de Oliveira, C. I., Santos-Muccillo, P., Bezerra, J. F., Teixeira, D. L. F., Riediger, I., Debur, M. C., Ribeiro-Rodrigues, R., Leite, A. B., do Santos, C. A., Gregianini, T. S., Fernandes, S. B., Bernardes, A. F. L., Cavalcanti, A. C., Miyajima, F., Sachhi, C., Mattos, T., da Costa, C. F., Delatorre, E., Wallau, G. L., Naveca, F. G., Bello, G., Siqueira, M. M.
10.1101/2021.03.12.434969 — Posted: 2021-03-13
The causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study
Cui, Z., Tian, Y.
10.1101/2021.03.08.21252901 — Posted: 2021-03-13
Engagement with daily testing instead of self-isolating in contacts of confirmed cases of SARS-CoV-2.
Martin, A. F., Denford, S., Love, N., Ready, D., Oliver, I., Amlot, R., Rubin, G. J., Yardley, L.
10.1101/2021.03.13.21253500 — Posted: 2021-03-13
The efficacy and safety of remdesivir in the treatment of patients with COVID-19: a systematic review and meta-analysis
Lou, L., Zhang, H., Li, Z., Tang, B., Li, Z.
10.1101/2021.03.12.21253470 — Posted: 2021-03-13
Rapid review of social contact patterns during the COVID-19 pandemic
Liu, C. Y., Berlin, J., Kiti, M. C., Del Fava, E., Grow, A., Zagheni, E., Melegaro, A., Jenness, S. M., Omer, S., Lopman, B., Nelson, K.
10.1101/2021.03.12.21253410 — Posted: 2021-03-13
Clinical characteristics of COVID-19 in children and adolescents: a systematic review and meta-analysis
Lou, L., Zhang, H., Tang, B., Li, M., Li, Z., Cao, H., Li, J., Chong, Y., Li, Z.
10.1101/2021.03.12.21253472 — Posted: 2021-03-13
Modeling the use of SARS-CoV-2 vaccination to safely relax non-pharmaceutical interventions
Kraay, A. N. M., Gallagher, M. E., Ge, Y., Han, P., Baker, J. M., Koelle, K., Handel, A., Lopman, B. A.
10.1101/2021.03.12.21253481 — Posted: 2021-03-13
All Models Are Useful: Bayesian Ensembling for Robust High Resolution COVID-19 Forecasting
Adiga, A., Wang, L., Hurt, B., Peddireddy, A. S., Porebski, P., Venkatramanan, S., Lewis, B., Marathe, M.
10.1101/2021.03.12.21253495 — Posted: 2021-03-13
New SARS-CoV-2 lineages could evade CD8+ T-cells response
Pretti, M. A. M., Galvani, R. G., Farias, A. S., Boroni, M.
10.1101/2021.03.09.434584 — Posted: 2021-03-13
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19
Peluso, M. J., Kelly, J. D., Lu, S., Goldberg, S. A., Davidson, M. C., Mathur, S., Durstenfeld, M. S., Spinelli, M. A., Hoh, R., Tai, V., Fehrman, E. A., Torres, L., Hernandez, Y., Williams, M. C., Arreguin, M. I., Bautista, J. A., Ngo, L. H., Deswal, M., Munter, S. E., Martinez, E. O., Anglin, K. A., Romero, M. D., Tavs, J., Rugart, P. R., Chen, J. Y., Sans, H. M., Murray, V. W., Ellis, P. K., Donohue, K. C., Massachi, J. A., Weiss, J. O., Mehdi, I., Pineda-Ramirez, J., Tang, A. F., Wegner, M., Assenzio, M., Yuan, Y., Krone, M., Rutishauser, R. L., Rodriguez-Barraquer, I., Greenhouse, B., Sauceda, J. A., Gandhi, M., Hsue, P., Henrich, T. J., Deeks, S. G., Martin, J. N.
10.1101/2021.03.11.21252311 — Posted: 2021-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).